Member AUM
$95 trillion
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
North America, Europe
GICS Sub-industry:
Pharmaceuticals



Dechra Pharmaceuticals was assessed in 2022/2023 and in 2023/2024. In January 2024, the company was delisted from the London Stock Exchange.

Animal Pharmaceuticals Engagement

Analysis Breakdown

This is a placeholder title for some members-only content

amet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consecteturamet lorem possimus elit sit ipsum dolor adipiscing quis consectetur

elit dolor sit quis possimus consectetur ipsum lorem adipiscing ametelit dolor sit quis possimus consectetur ipsum lorem adipiscing ametelit dolor sit quis possimus consectetur ipsum lorem adipiscing ametelit dolor sit quis possimus consectetur ipsum lorem adipiscing amet

sit adipiscing elit quis consectetur dolor ipsum lorem possimus ametsit adipiscing elit quis consectetur dolor ipsum lorem possimus ametsit adipiscing elit quis consectetur dolor ipsum lorem possimus ametsit adipiscing elit quis consectetur dolor ipsum lorem possimus ametsit adipiscing elit quis consectetur dolor ipsum lorem possimus amet

adipiscing dolor consectetur ipsum amet sit lorem possimus elit quisadipiscing dolor consectetur ipsum amet sit lorem possimus elit quis

lorem ipsum possimus consectetur elit quis sit amet dolor adipiscinglorem ipsum possimus consectetur elit quis sit amet dolor adipiscing

Members-only Content

To register as a member of the FAIRR network, please fill out the sign up form or if you need additional information on the FAIRR network, please contact investoroutreach@fairr.org.